Integral Health Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Integral Health Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,000	Closed	-$1.86M	–	94
2022 Q3	$1.86M	Buy	+30,000	New	+$2.1M	0.36%	60
2022 Q1	–	Sell	-30,000	Closed	-$3.23M	–	89
2021 Q4	$3.23M	Sell	30,000 -30,000	-50%	-$3.27M	0.89%	37
2021 Q3	$6.57M	Buy	+60,000	New	+$6.23M	1.89%	17
2021 Q2	–	Sell	-40,000	Closed	-$3.68M	–	94
2021 Q1	$3.68M	Buy	+40,000	New	+$3.38M	1.05%	37
2020 Q4	–	Sell	-30,000	Closed	-$2.33M	–	90
2020 Q3	$2.33M	Sell	30,000 -50,000	-63%	-$3.44M	0.71%	52
2020 Q2	$4.45M	Buy	+80,000	New	+$3.42M	1.33%	32

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Integral Health Asset Management's HZNP Position: Q4 2022 in Review

Integral Health Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 30,000 shares — an estimated $1.86M sold.

Integral Health Asset Management first reported a position in HZNP in Q2 2020 and held it in 6 quarters. The position peaked at $6.57M in Q3 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Integral Health Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Integral Health Asset Management sold 30,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $1.86M.
Integral Health Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 6 quarters.
Integral Health Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6.57M in Q3 2021.
615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Integral Health Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.